Related Experiment Video
Updated: Nov 25, 2025

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer's Disease
Fanny Eysert1, Paula Fernanda Kinoshita1,2, Arnaud Mary1
1Université Côte d'Azur, INSERM, CNRS, Institut of Molecular and Cellular Pharmacology, Laboratory of Excellence DistalZ, Sophia-Antipolis, 06560 Valbonne, France.
Abstract:
Alzheimer's disease (AD) is a multifactorial neurodegenerative pathology characterized by a progressive decline of cognitive functions. Alteration of various signaling cascades affecting distinct subcellular compartment functions and their communication likely contribute to AD progression. Among others, the alteration of the physical association between the endoplasmic reticulum (ER) and mitochondria, also reffered as mitochondria-associated membranes (MAMs), impacts various cellular housekeeping functions such as phospholipids-, glucose-, cholesterol-, and fatty-acid-metabolism, as well as calcium signaling, which are all altered in AD. Our review describes the physical and functional proteome crosstalk between the ER and mitochondria and highlights the contribution of distinct molecular components of MAMs to mitochondrial and ER dysfunctions in AD progression. We also discuss potential strategies targeting MAMs to improve mitochondria and ER functions in AD.
Insights
Alzheimer's disease involves impaired communication between the endoplasmic reticulum (ER) and mitochondria. Targeting these mitochondria-associated membranes (MAMs) may offer new therapeutic strategies for cognitive decline.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Alzheimer's disease (AD) is a neurodegenerative disorder causing cognitive decline.
- Dysfunctional cellular signaling and communication between subcellular compartments contribute to AD.
- Alterations in mitochondria-associated membranes (MAMs), the interface between ER and mitochondria, are implicated in AD.
Purpose of the Study:
- To review the proteomic crosstalk between the ER and mitochondria.
- To highlight the role of MAMs in ER and mitochondrial dysfunction in AD.
- To discuss potential therapeutic strategies targeting MAMs for AD.
Main Methods:
- Literature review of studies on ER-mitochondria crosstalk in AD.
- Analysis of proteomic data related to MAMs.
- Synthesis of current understanding of MAMs' role in AD pathogenesis.
Main Results:
- MAMs are crucial for cellular functions including metabolism and calcium signaling, which are altered in AD.
- Specific molecular components of MAMs contribute to mitochondrial and ER dysfunction in AD.
- Dysregulation of MAMs impacts multiple cellular processes relevant to AD.
Conclusions:
- MAMs represent a key nexus of cellular dysfunction in Alzheimer's disease.
- Targeting MAMs offers a promising avenue for developing novel AD therapeutics.
- Further research into MAMs' molecular components and functions is warranted for AD treatment.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Mitochondria
Mitochondrial Membranes
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

